BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Factor Bioscience Files Patent Infringement Lawsuit Against Cellectis and AstraZeneca

Factor Bioscience Inc. (Factor), a Cambridge, Massachusetts-based biotechnology company focused on using its pioneering gene-editing platform to devel...

September 29, 2025 | News

Leo Cancer Care and Sumitomo Heavy Industries Partner to Launch Upright Proton Therapy Solution

Leo Cancer Care, a leader in innovative cancer care solutions, and Sumitomo Heavy Industries, a global pioneer in medical technology, have announced a stra...

September 29, 2025 | News

GCCL and Frontage Laboratories Sign Strategic MOU to Strengthen Global Clinical Trial Capabilities

GCCL (Global Clinical Central Lab), a South Korea-based leading provider of clinical trial sample analysis, and Frontage Laboratories, Inc., a US...

September 25, 2025 | News

South Korea’s Celltrion Buys Eli Lilly’s Branchburg Plant in $330M Deal

Celltrion Group announced that its US subsidiary, Celltrion USA, has entered into a definitive agreement to acquire Eli Lilly’s biologics manufacturi...

September 25, 2025 | News

Lonza and RION Partner to Scale Manufacturing of Exosome-Based Therapy PEP™

Lonza to support cGMP manufacturing of RION’s Purified Exosome Product™ (PEP™), a platelet-derived exosome-based drug candidate ...

September 24, 2025 | News

The $100 Billion Question: Can India Lead the Global Diabetes Economy?

India’s Diabetes Burden and Global Stakes: India is often called the “diabetes capital of the world,” and not without reason. Recent esti...

September 24, 2025 | Analysis | By editor@biopharmaapac.com

Merck Opens €150 Million Climate-Neutral Filter Manufacturing Facility in Cork

Part of company’s €440 million investment in Ireland, strengthens Merck’s in-region-for-region supply resilience Merck’s firs...

September 23, 2025 | News

Merck and Siemens Forge Digital Alliance to Transform Drug Discovery and Manufacturing

Memorandum of Understanding signed to deliver end-to-end digital workflows from drug discovery to manufacturing Combines technology from the Siemens...

September 24, 2025 | News

Thermo Fisher Introduces Hypulse™ System to Transform XPS Depth-Profiling

Thermo Fisher Scientific, the world leader in serving science, has introduced the Thermo Scientific™ Hypulse™ Surface Analysis System. This inn...

September 23, 2025 | News

China’s NMPA Approves Innovent’s Mazdutide, the World’s First Dual GCG/GLP-1 Receptor Agonist for Type 2 Diabetes

Innovent Biologics, Inc. a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatm...

September 22, 2025 | News

Alnylam Joins Illumina and NashBio’s Alliance for Genomic Discovery

Alnylam, a leader in RNA interference (RNAi) therapeutics, will utilize the AGD dataset to inform development of 'gene silencing' medicines Members levera...

September 19, 2025 | News

Roche Wins First CLIA ‘Moderate Complexity’ Designation for Mass Spectrometry Vitamin D Test

First mass spectrometry-based test system for total 25-Hydroxyvitamin D to receive CLIA 'Moderate Complexity' designation in the U.S....

September 19, 2025 | News

WuXi Biologics Secures First Turkish GMP Certification for Three Facilities

WuXi Biologics (2269.HK), a leading global Contract Research, Development, and Manufacturing Organization (CRDMO), announced that three of its manufacturin...

September 18, 2025 | News

Mabwell and Aditum Bio Launch Kalexo Bio with $1 Billion siRNA Deal for Dyslipidemia and ASCVD

Mabwell (Shanghai) Bioscience Co., Ltd. (688062.SH) and Aditum Bio announced the launch of Kalexo Bio, a new company formed in conjunction with an exc...

September 18, 2025 | News

Stay Connected